{
    "Trade/Device Name(s)": [
        "ARCHITECT iPhenobarbital Assay",
        "ARCHITECT iPhenobarbital Calibrators (A-F)"
    ],
    "Submitter Information": "Abbott Laboratories",
    "510(k) Number": "K081231",
    "Predicate Device Reference 510(k) Number(s)": [
        "K940596"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DLZ",
        "DLJ"
    ],
    "Summary Letter Date": "September 26, 2008",
    "Summary Letter Received Date": "September 10, 2008",
    "Submission Date": "September 9, 2008",
    "Regulation Number(s)": [
        "21 CFR 862.3660",
        "21 CFR 862.3200"
    ],
    "Regulation Name(s)": [
        "Phenobarbital test system",
        "Calibrator, drug specific"
    ],
    "Analyte Class(es)": [
        "toxicology",
        "tdm"
    ],
    "Analyte(s)": [
        "Phenobarbital"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "ARCHITECT i System"
    ],
    "Method(s)/Technology(ies)": [
        "Chemiluminescent microparticle immunoassay (CMIA)"
    ],
    "Methodologies": [
        "Immunoassay",
        "Chemiluminescent measurement"
    ],
    "Submission Type(s)": [
        "Assay",
        "Calibrator"
    ],
    "Document Summary": "FDA 510(k) summary for ARCHITECT iPhenobarbital assay and calibrators for quantitative measurement of phenobarbital in serum or plasma using CMIA technology.",
    "Indications for Use Summary": "Quantitative measurement of phenobarbital in human serum or plasma to assist in diagnosis, treatment of overdose, and monitoring therapeutic levels.",
    "fda_folder": "Toxicology"
}